Login / Signup

SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus - an analysis of anti-double-stranded DNA monitoring.

Ai Li YeoRangi Kandane-RathnayakeRachel KoelmeyerVera GolderWorawit LouthrenooYi-Hsing ChenJiacai ChoAisha LateefLaniyati HamijoyoShue-Fen LuoYeong-Jian J WuSandra V NavarraLeonid D ZamoraZhan-Guo LiYuan AnSargunan SockalingamYasuhiro KatsumataMasayoshi HarigaiYanjie HaoZhuoli ZhangB M D B BasnayakeMadelynn ChanJun KikuchiTsutomu TakeuchiSang-Cheol BaeShereen OonSean O'NeillFiona GoldblattKristine Pek Ling NgAnnie LawNicola TugnetSunil KumarCherica A TeeMichael Lucas TeeNaoaki OhkuboYoshiya TanakaWallace Chak Sing LauMandana NikpourAlberta Y HoiMichelle LeechEric F Morandnull null
Published in: Rheumatology (Oxford, England) (2023)
Absolute value and change in anti-dsDNA titres predict flares, including in persistently anti-dsDNA positive patients. This indicates that repeat monitoring of dsDNA has value in routine testing.
Keyphrases
  • ejection fraction
  • systemic lupus erythematosus
  • end stage renal disease
  • newly diagnosed
  • prognostic factors
  • binding protein
  • circulating tumor
  • single molecule